ExomeCG to simplify molecular and cytogenomic data generation and interpretation

Read More

Prenatal exome sequencing in unexplained fetal oedema: a game changer

Read More

Congenica brings together Mastermind, DECIPHER and Sentieon in major product update

Read More

Congenica Integrates Powerful New Curated Data

Read More

Highlights from the International Conference on Prenatal Diagnosis and Therapy

Read More

Congenica a finalist in multiple industry awards

Read More

Congenica simplifies software branding and enhances platform with CNV calling to deliver genomic medicine globally

Read More

Congenica named in UK life sciences – Catalysing investment and growth report

Read More

BGI Genomics Launch Clinical Research Whole Exome Sequencing and Interpretation Service Using Congenica Clinical Decision Support Platform

Read More

Congenica supports fast, meaningful results achieved in important project

Read More

Congenica Raises Additional £13.25M ($17.1M) to Reach Total of £23.3M ($30.1M) for Series B Funding Round

Read More

ExomeCG to simplify molecular and cytogenomic data generation and interpretation

Read More

Prenatal exome sequencing in unexplained fetal oedema: a game changer

Read More

Congenica brings together Mastermind, DECIPHER and Sentieon in major product update

Read More

Congenica Integrates Powerful New Curated Data

Read More

Highlights from the International Conference on Prenatal Diagnosis and Therapy

Read More

Congenica a finalist in multiple industry awards

Read More

Congenica simplifies software branding and enhances platform with CNV calling to deliver genomic medicine globally

Read More

Congenica named in UK life sciences – Catalysing investment and growth report

Read More

BGI Genomics Launch Clinical Research Whole Exome Sequencing and Interpretation Service Using Congenica Clinical Decision Support Platform

Read More

Congenica supports fast, meaningful results achieved in important project

Read More

Congenica Raises Additional £13.25M ($17.1M) to Reach Total of £23.3M ($30.1M) for Series B Funding Round

Read More